Health● Low49m ago · Nov 13, 2026, 5:00 AM

Lula's promise, cheaper pens only approved for diabetes, which may block supply in SUS; Anvisa evaluates two requests for obesity

GlobeAlert Desk · curated from G1 · Brazil · South America

Anvisa approves registration of 5 new semaglutide-based weight-loss pens. Promised by Lula (PT) during the campaign, having weight-loss pens in the SUS faces a detail in the leaflet: the cheaper versions, which entered the market after the semaglutide patent expired, are only registered with the Agency

Read at G1 Ask the Analyst about this

GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.

GlobeAlert context

What the desk knows about this story

Threat level

1 Low

Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.

Sources

1 publisher

Single-source so far. Treat details as unconfirmed until more publishers report.

More from Brazil

Disaster2h agoNJ construction worker in deadly Long Island bridge scaffolding collapse ID’d as brother of Brazilian polNY Post · United States World3h agoAfter suffering in the World Cup, Brazil revisits Japan trying to show a new faceFolha de S.Paulo · Brazil World3h agoNear the Proclamation of the Republic, see films about the untold stories of Brazilian historyFolha de S.Paulo · Brazil Business7h agoBrazilian meat company MBRF gains 46% more until SeptemberInfobae · Argentina

More in Health

Health27m agoDelhi overtakes Lahore as world's most polluted city as air quality dropsThe Hindu Health44m agoFructose and cancer spread.. study reveals unexpected mechanismSky News Arabia · United Arab Emirates Health49m ago5.3 million Brazilians have diabetes and don't know it; simple online test helps understand risk of developing the diseaseG1 · Brazil Health49m agoProstate cancer: how robotic surgery, focal treatments and artificial intelligence change its approachInfobae · Argentina